By H2 Dec 2025, Methyl Amine prices in the United States edged higher as the market balance began to tighten slightly. Availability in the spot market became slightly tighter, which reduced pricing flexibility and allowed sellers to hold onto higher levels. Buyers, while still cautious, adjusted to the new price range rather than delaying purchases entirely. With inventories kept lean and expectations of further adjustments circulating in the market, prices managed to move up, even though overall buying sentiment remained restrained and measured.
Ammonia availability in the US Gulf Coast has improved as a feedstock for Methyl Amine manufacturers, leading to stronger economic returns for manufacturers using ammonia as a feedstock. The additional ammonia that is now making its way into the marketplace can be traced back to the gradual initiation of operations at Gulf Coast Ammonia's (GCA) newly constructed facility of 1.2 million tonnes per year, which is preparing for its full commercial launch in early 2026, having been in development since November. Woodside Energy is also anticipated to begin commercial operations for its Beaumont, Texas ammonia plant (1.1 million t/year) in early 2026 as well. These two projects, when operational, will provide a significant increase in ammonia availability and likely alleviate some cost-push pressure on Methyl Amine manufacturers.
Methanol prices have reduced due to relatively large methanol inventories and continuous methanol production from North American producers. In addition, these deteriorating conditions in the methanol market have reduced the likelihood of an increase in the cost of producing Methyl Amine products, thus stabilizing the suppliers' offers and limiting the need for price adjustments.
The pharmaceutical industry has received moderate but weak support due to the lack of significant growth in revenue and earnings over the past three years within the U.S. pharmaceutical industry, causing potential purchasers of Methyl Amine for pharmaceutical intermediates to continue exhibiting extreme caution in their purchasing decisions and preferring to enter into contracts rather than to purchase for forward stocking purposes.
Intentional actions from suppliers were key drivers for price increases. The production schedules of Methyl Amine manufacturers closely matched their confirmed purchase orders, which prevented excess inventories that could negatively impact prices from accumulating. Supply discipline was still being exercised by producers, as they delivered to only contracted customers and controlled how they allocate their resources. Producers also carefully released limited quantities and specific amounts of spot volume, this meant that increased supply wouldn’t have a negative impact on prices. The control over supply created tighter market access and enabled suppliers to provide higher prices for Methyl Amine. Manufacturers effectively built price momentum, thus maintaining a balanced order fulfilment system by restricting access to all excessive supplies of Methyl Amine in the spot market.
As per the ChemAnalyst anticipation the price of the Methyl Amine is expected to showcase stability in the upcoming sessions. The availability of feedstock, the decline in methanol prices, a weakened demand for pharmaceuticals, and the careful management of stocks by suppliers will enable Methyl Amine to maintain a steady market price. As such, there is little chance that changes on either the supplier side or the buyer side will create significant disruption to current market pricing levels for Methyl Amine within the short term.
